[1] Jia M, Zhang H, Qin Q, et al. Ferroptosis as a new therapeutic opportunity for nonviral liver disease[J]. Eur J Pharmacol, 2021,908: 174319. [2] 张誉, 杨永峰. 不明原因肝硬化的病理诊断思路[J]. 临床肝胆病杂志, 2023,39(03): 498-503. [3] Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020[J]. J Gastroenterol, 2021,56(7): 593-619. [4] 杨永峰. 不明原因肝病诊断思路[J]. 实用肝脏病杂志, 2018,21(01): 1-3. [5] 张思敏, 周海东, 赵琳, 等. 不明原因肝功能异常患者的病因分析[J]. 肝脏, 2014,19(01): 31-33. [6] Khalifa A, Lewin D N, Sasso R, et al. The utility of liver biopsy in the evaluation of liver disease and abnormal liver function tests[J]. Am J Clin Pathol, 2021,156(2): 259-267. [7] Chowdhury A B, Mehta K J. Liver biopsy for assessment of chronic liver diseases: a synopsis[J]. Clin Exp Med, 2023,23(2): 273-285. [8] Khalifa A, Rockey D C. The value of liver biopsy and histology in liver disease diagnosis and patient care-a pragmatic prospective clinical practice study[J]. J Clin Gastroenterol, 2024,58(9): 912-916. [9] Pirmoazen A M, Khurana A, EI Kaffas A, et al. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease[J]. Theranostics, 2020,10(9): 4277-4289. [10] Ferraioli G, Soares Monteiro L B. Ultrasound-based techniques for the diagnosis of liver steatosis[J]. World J Gastroenterol, 2019,25(40): 6053-6062. [11] 熊清芳, 杨永峰. 不明原因胆汁淤积诊断思路[J]. 实用肝脏病杂志, 2018,21(01): 18-20. [12] Björnsson H K, Björnsson E S. Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management[J]. Eur J Intern Med, 2022,97: 26-31. [13] 马世武, 刘成海, 刘晓琰, 等. 中国药物性肝损伤诊治指南(2023年版)[J]. 胃肠病学, 2022,27(06): 341-375. [14] Adams D R, Eng C M. Next-generation sequencing to diagnose suspected genetic disorders[J]. N Engl J Med, 2019,380(2): 201. [15] Guindi M. Wilson disease[J]. Semin Diagn Pathol, 2019,36(6): 415-422. [16] 沈乃欢,高全绪,宋振山,等. 慢性胆囊炎胆石症所致肝损害及治疗意见——(附50例病例)[J]. 临床肝胆病杂志, 1992(01): 39-40. [17] 孙艳华, 林之莓, 项晓刚, 等. 不明原因肝功能异常2510例临床资料分析[J]. 肝脏, 2016,21(08): 623-625. |